Mercer Global Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6M Sell
31,663
-16,313
-34% -$2.42M 0.01% 801
2026
Q1
$4.47M Buy
47,976
+44,255
+1,189% +$3.92M 0.01% 806
2025
Q4
$299K Buy
3,721
+951
+34% +$79.6K ﹤0.01% 2230
2025
Q3
$270K Buy
+2,770
New +$223K ﹤0.01% 2168
2023
Q2
Sell
-2,236
Closed -$298K 1917
2023
Q1
$298K Buy
+2,236
New +$263K ﹤0.01% 1515

Other funds holding ACLS

Mercer Global Advisors's ACLS Position: Q2 2026 in Review

Mercer Global Advisors reduced its Axcelis (ACLS) stake by 34% in Q2 2026, selling an estimated $2.42M and leaving 31,663 shares worth $6M. The position accounts for 0.01% of the portfolio, ranked #801.

Mercer Global Advisors first reported a position in ACLS in Q1 2023 and has held it in 5 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Mercer Global Advisors held 31,663 shares of Axcelis worth $6M as of Q2 2026.
  • Mercer Global Advisors sold 16,313 Axcelis shares in Q2 2026, an estimated $2.42M.
  • Axcelis made up 0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #801 holding.
  • Mercer Global Advisors first reported a position in Axcelis in Q1 2023 and has held it in 5 quarters since.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.